Abstract
Overexpression of ErbB2 and ErbB4 receptors in breast cancers may be accompanied by contrasting clinical outcomes. To investigate the molecular mechanisms contributing to these differences, we undertook a comparative study of gene expression regulated by the two receptors. Agonistic antibodies were employed to activate ErbB2 and ErbB4 in isolation from the other ErbBs in breast cancer cells. Gene expression profiling using a 16 755-gene oligonucleotide array was performed to identify transcriptional targets of receptor activation. Our results indicate that, in the same cell line, ErbB2 and ErbB4 activation influence gene transcription differentially. Although there are genes that are regulated by signaling from both receptors, there are also receptor-specific targets that are preferentially regulated by each receptor. We further show that two ligands acting via the same receptor homodimer may activate different subsets of genes. Many of the induced genes are hitherto unidentified targets of ErbB signaling. These include ErbB4 targets EPS15R, GATA4, and RAB2 and ErbB2-activated HRY/HES1 and PPAP2A. Targets of ErbB2 homodimer signaling may be especially important as markers in breast cancer, where ErbB2 homodimerization mediated by overexpression and ligand-independent activation is common.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alaoui-Jamali MA, Song DJ, Benlimame N, Yen L, Deng X, Hernandez-Perez M and Wang T . (2003). Cancer Res., 63, 3764–3774.
Andrechek ER, Laing MA, Girgis-Gabardo AA, Siegel PM, Cardiff RD and Muller WJ . (2003). Cancer Res., 63, 4920–4926.
Bacus SS, Chin D, Zelnick CR and Stern DF . (1996). Am. J. Pathol., 148, 549–558.
Baulida J, Kraus M, Alimandi M, Di Fiore P and Carpenter G . (1996). J. Biol. Chem., 271, 5251–5257.
Burke CL and Stern DF . (1998). Mol. Cell. Biol., 18, 5371–5379.
Chen X, Levkowitz G, Tzahar E, Karunagaran D, Lavi S, Ben-Baruch N, Leitner O, Ratzkin BJ, Bacus SS and Yarden Y . (1996). J. Biol. Chem., 271, 7620–7629.
Chuaqui RF, Bonner RF, Best CJ, Gillespie JW, Flaig MJ, Hewitt SM, Phillips JL, Krizman DB, Tangrea MA, Ahram M, Linehan WM, Knezevic V and Emmert-Buck MR . (2002). Nat. Genet., 32, 509–514.
Cohen B, Green J, Foy L and Fell H . (1996). J. Biol. Chem., 271, 4813–4818.
da Silva AJ, Brickelmaier M, Majeau GR, Lukashin AV, Peyman J, Whitty A and Hochman PS . (2002). J. Interferon Cytokine Res., 22, 173–188.
Decker SJ . (1990). Biochem. Biophys. Res. Commun., 66, 615–621.
DiFiore PP, Pierce JH, Kraus MH, Segatto O, King CR and Aaronson SA . (1987). Science, 237, 178–182.
Dupont J, Dunn SE, Barrett JC and LeRoith D . (2003). Recent Prog. Horm. Res., 58, 325–342.
Dupont J, Khan J, Qu BH, Metzler P, Helman L and LeRoith D . (2001). Endocrinology, 142, 4969–4975.
Evans PC, Taylor ER, Coadwell J, Heyninck K, Beyaert R and Kilshaw PJ . (2001). Biochem. J., 357, 617–623.
Fambrough D, McClure K, Kazlauskas A and Lander ES . (1999). Cell, 97, 727–741.
Ferguson KM, Berger MB, Mendrola JM, Cho HS, Leahy DJ and Lemmon MA . (2003). Mol. Cell, 11, 507–517.
Gassmann M, Casagranda F, Orioli D, Simon H, Lai C, Klein R and Lemke G . (1995). Nature, 378, 390–394.
Geymayer S and Doppler W . (2000). FASEB J., 14, 1159–1170.
Graus-Porta D, Beerli R, Daly J and Hynes N . (1997). EMBO J., 16, 1647–1655.
Graus-Porta D, Beerli RR and Hynes NE . (1995). Mol. Cell. Biol., 15, 1182–1191.
Halgren RG, Fielden MR, Fong CJ and Zacharewski TR . (2001). Nucleic Acids Res., 29, 582–588.
Hirata H, Yoshiura S, Ohtsuka T, Bessho Y, Harada T, Yoshikawa K and Kageyama R . (2002). Science, 298, 840–843.
Hobbs SS, Coffing SL, Le AT, Cameron EM, Williams EE, Andrew M, Blommel EN, Hammer RP, Chang H and Riese II DJ . (2002). Oncogene, 21, 8442–8452.
Hynes NE and Stern DF . (1994). Biochem. Biophys. Acta Rev. Cancer, 1198, 165–184.
Jones FE and Stern DF . (1999). Oncogene, 18, 3481–3490.
Jones FE, Welte T, Fu XY and Stern DF . (1999). J. Cell Biol., 147, 77–88.
Kew TY, Bell JA, Pinder SE, Denley H, Srinivasan R, Gullick WJ, Nicholson RI, Blamey RW and Ellis IO . (2000). Br. J. Cancer, 82, 1163–1170.
Knowlden J, Gee J, Seery L, Farrow L, Gullick W, Ellis I, Blamey R, Robertson J and Nicholson R . (1998). Oncogene, 17, 1949–1957.
Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP and Chinnaiyan AM . (2003). Cancer Res., 63, 132–139.
Lee K-F, Simon H, Chen H, Bates B, Hung M-C and Hauser C . (1995). Nature, 378, 394–398.
Lenferink AE, Pinkas-Kramarski R, van de Poll ML, van Vugt MJ, Klapper LN, Tzahar E, Waterman H, Sela M, van Zoelen EJ and Yarden Y . (1998). EMBO J., 17, 3385–3397.
Lesa GM and Sternberg PW . (1997). Mol. Biol. Cell, 8, 779–793.
Li L, Cleary S, Mandarano MA, Long W, Birchmeier C and Jones FE . (2002). Oncogene, 21, 4900–4907.
Mackay A, Jones C, Dexter T, Silva RL, Bulmer K, Jones A, Simpson P, Harris RA, Jat PS, Neville AM, Reis LF, Lakhani SR and O'Hare MJ . (2003). Oncogene, 22, 2680–2688.
Marshall CJ . (1995). Cell, 80, 179–185.
Mulligan C, Rochford J, Denyer G, Stephens R, Yeo G, Freeman T, Siddle K and O'Rahilly S . (2002). J. Biol. Chem., 277, 42480–42487.
Muthuswamy SK, Li D, Lelievre S, Bissell MJ and Brugge JS . (2001). Nat. Cell Biol., 3, 785–792.
Neve RM, Holbro T and Hynes NE . (2002). Oncogene, 21, 4567–4576.
Oh JJ, Grosshans DR, Wong SG and Slamon DJ . (1999). Nucleic Acids Res., 27, 4008–4017.
Ohtsuka T, Ishibashi M, Gradwohl G, Nakanishi S, Guillemot F and Kageyama R . (1999). EMBO J, 18, 2196–2207.
Olayioye MA, Graus-Porta D, Beerli RR, Rohrer J, Gay B and Hynes NE . (1998). Mol. Cell. Biol., 18, 5042–5051.
Olayioye MA, Neve RM, Lane HA and Hynes NE . (2000). EMBO J., 19, 3159–3167.
Ota T, Fujii M, Sugizaki T, Ishii M, Miyazawa K, Aburatani H and Miyazono K . (2002). J. Cell. Physiol., 193, 299–318.
Pawson T and Saxton TM . (1999). Cell, 97, 675–678.
Penington DJ, Bryant I and Riese II DJ . (2002). Cell Growth Differ., 13, 247–256.
Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO and Botstein D . (1999). Proc. Natl. Acad. Sci. USA, 96, 9212–9217.
Plowman G, Green J, Culouscou J-M, Carlton G, Rothwell V and Buckley S . (1993). Nature, 366, 473–475.
Pollard JW and Hennighausen L . (1994). Proc. Natl. Acad. Sci. USA, 91, 9312–9316.
Pupa SM, Menard S, Morelli D, Pozzi B, De Palo G and Colnaghi MI . (1993). Oncogene, 8, 2917–2923.
Rangel LB, Agarwal R, D'Souza T, Pizer ES, Alo PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR and Morin PJ . (2003). Clin. Cancer Res., 9, 2567–2575.
Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM and Horwitz KB . (2002). J. Biol. Chem., 277, 5209–5218.
Riese DI, van Raaij T, Plowman G, Andrews G and Stern D . (1995). Mol. Cell. Biol., 15, 5770–5776.
Riese II DJ and Stern DF . (1998). BioEssays, 20, 41–48.
Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D and Brown PO . (2000). Nat. Genet., 24, 227–235.
Sapi E, Flick MB, Rodov S, Carter D and Kacinski BM . (1998). J. Soc. Gynecol. Investig., 5, 94–101.
Sartor CI, Zhou H, Kozlowska E, Guttridge K, Kawata E, Caskey L, Harrelson J, Hynes N, Ethier S, Calvo B and Earp III HS . (2001). Mol. Cell. Biol., 21, 4265–4275.
Sasai Y, Kageyama R, Tagawa Y, Shigemoto R and Nakanishi S . (1992). Genes Dev., 6, 2620–2634.
Schroeder JA and Lee DC . (1998). Cell Growth Differ., 9, 451–464.
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL . (1987). Science, 235, 177–182.
Srinivasan R, Poulsom R, Hurst H and Gullick W . (1997). J. Pathol., 185, 236–245.
Stancovski I, Hurwitz E, Leitner O, Ullrich A, Yarden Y and Sela M . (1991). Proc. Natl. Acad. Sci. USA, 88, 8691–8695.
Stern D . (2000). Breast Cancer Res., 2, 176–183.
Stern DF . (2003). Exp. Cell Res., 284, 89–98.
Suo Z, Risberg B, Kalsson MG, Willman K, Tierens A, Skovlund E and Nesland JM . (2002). J. Pathol., 196, 17–25.
Sweeney C, Fambrough D, Huard C, Diamonti AJ, Lander ES, Cantley LC and Carraway III KL . (2001). J. Biol. Chem., 276, 22685–22698.
Sweeney C, Lai C, Riese II DJ, Diamonti AJ, Cantley LC and Carraway III KL . (2000). J. Biol. Chem., 275, 19803–19807.
Tang CK, Concepcion XZ, Milan M, Gong X, Montgomery E and Lippman ME . (1999). Cancer Res., 59, 5315–5322.
Taylor E, Cogdell D, Coombes K, Hu L, Ramdas L, Tabor A, Hamilton S and Zhang W . (2001). Biotechniques, 31, 62–65.
Tidcombe H, Jackson-Fisher A, Mathers K, Stern DF, Gassman M and Golding JP . (2003). Proc. Natl. Acad. Sci. USA, 100, 8281–8286.
Tisdale EJ . (1999). Mol. Biol. Cell, 10, 1837–1849.
Tseng GC, Oh MK, Rohlin L, Liao JC and Wong WH . (2001). Nucleic Acids Res., 29, 2549–2557.
Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, Lavi S, Ratzkin BJ and Yarden Y . (1996). Mol. Cell. Biol., 16, 5276–5287.
Vadlamudi RK, Wang RA, Talukder AH, Adam L, Johnson R and Kumar R . (2000). Mol. Cell. Biol., 20, 9092–9101.
Vecchi M, Baulida J and Carpenter G . (1996). J. Biol. Chem., 271, 18989–18995.
Vogt U, Bielawski K, Schlotter C, Bosse U, Falkiewicz B and Podhajska A . (1998). Gene, 223, 375–380.
Waterman H, Sabanai I, Geiger B and Yarden Y . (1998). J. Biol. Chem., 273, 13819–13827.
Weijzen S, Rizzo P, Braid M, Vaishnav R, Jonkheer SM, Zlobin A, Osborne BA, Gottipati S, Aster JC, Hahn WC, Rudolf M, Siziopikou K, Kast WM and Miele L . (2002). Nat. Med., 8, 979–986.
Williams EE, Trout LJ, Gallo RM, Pitfield SE, Bryant I, Penington DJ and Riese II DJ . (2003). Cancer Lett., 192, 67–74.
Wilson KS, Roberts H, Leek R, Harris AL and Geradts J . (2002). Am. J. Pathol., 161, 1171–1185.
Witton CJ, Reeves JR, Going JJ, Cooke TG and Bartlett JM . (2003). J. Pathol., 200, 290–297.
Yarden Y and Sliwkowski MX . (2001). Nat. Rev. Mol. Cell Biol., 2, 127–137.
Yip SS, Crew AJ, Gee JM, Hui R, Blamey RW, Robertson JF, Nicholson RI, Sutherland RL and Daly RJ . (2000). Int. J. Cancer, 88, 363–368.
Zhou W and Carpenter G . (2002). Inflamm. Res., 51, 91–101.
Acknowledgements
This work was supported by US Public Health Service Grant R01CA80065 from the National Cancer Institute.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Amin, D., Perkins, A. & Stern, D. Gene expression profiling of ErbB receptor and ligand-dependent transcription. Oncogene 23, 1428–1438 (2004). https://doi.org/10.1038/sj.onc.1207257
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207257